These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8591697)

  • 41. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes.
    Dornhorst A; Davies M; Anyaoku V; Hampton SM; Elkeles RS; Beard RW; Johnston DG
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):211-3. PubMed ID: 2036730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.
    Duckworth WC; Solomon SS; Kitabchi AE
    J Clin Endocrinol Metab; 1972 Oct; 35(4):585-91. PubMed ID: 5052977
    [No Abstract]   [Full Text] [Related]  

  • 43. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance.
    Hanson U; Persson B; Hartling SG; Binder C
    Diabetes Care; 1996 Jan; 19(1):17-20. PubMed ID: 8720527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excessive secretion of insulin precursors characterizes and predicts gestational diabetes.
    Swinn RA; Wareham NJ; Gregory R; Curling V; Clark PM; Dalton KJ; Edwards OM; O'Rahilly S
    Diabetes; 1995 Aug; 44(8):911-5. PubMed ID: 7621996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation.
    von Berghes C; Brabant G; Biebermann H; Krude H; Wiegand S
    Pediatr Diabetes; 2011 May; 12(3 Pt 2):242-9. PubMed ID: 21518412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
    Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
    Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The clinical significance of true insulin and proinsulin levels in subjects with different glucose tolerance].
    Yang J; Li M; Wu C
    Zhonghua Nei Ke Za Zhi; 2000 Dec; 39(12):811-3. PubMed ID: 11798541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range.
    Lorenzo C; Hanley AJ; Rewers MJ; Haffner SM
    Acta Diabetol; 2014 Aug; 51(4):617-23. PubMed ID: 24532116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.
    Mooy JM; Grootenhuis PA; de Vries H; Kostense PJ; Popp-Snijders C; Bouter LM; Heine RJ
    Diabetologia; 1996 Mar; 39(3):298-305. PubMed ID: 8721775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers.
    Wang PW; Abbasi F; Carantoni M; Chen YD; Azhar S; Reaven GM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3221-4. PubMed ID: 9329342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.
    Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG
    Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.
    Nijpels G; Popp-Snijders C; Kostense PJ; Bouter LM; Heine RJ
    Diabetologia; 1996 Jan; 39(1):113-8. PubMed ID: 8720611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
    Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M
    Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes.
    Smith SA; Porter LE; Biswas N; Freed MI
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6048-53. PubMed ID: 15579757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.